mRNA-Impfstoffe: Schutz vor Intensivstation auch ohne booster über 12 Monate

Duration of COVID-19 mRNA Vaccine Effectiveness against Severe Disease | medRxiv

medRxiv - The Preprint Server for Health Sciences

https://www.medrxiv.org/content/10.1101/2022.04.12.22273745v1